BioInvent International Aktiebolag (BINV.ST)

Nasdaq Stockholm · Financial statements, TTM figures and earnings dates

In fiscal year 2024 (ended December 31, 2024), BioInvent International Aktiebolag reported revenue of SEK 44.7M and net income of −SEK 429.4M. Annual financial statements are available for fiscal years 2020 to 2024, taken from the company's ESEF annual reports (IFRS).

Open interactive financials →

Key financials

SEK	FY2024 2024-12-31	FY2023 2023-12-31	FY2022 2022-12-31	FY2021 2021-12-31	FY2020 2020-12-31
Income statement
Revenue	SEK 44.7M	SEK 71.5M	SEK 326.1M	SEK 19.4M	SEK 147.4M
Operating income	−SEK 471.1M	−SEK 369.9M	−SEK 50.9M	−SEK 278.4M	−SEK 75.5M
Net income	−SEK 429.4M	−SEK 330.3M	−SEK 42.5M	−SEK 278.4M	−SEK 76.3M
Diluted EPS	−SEK 6.53	−SEK 5.02	−SEK 0.69	−SEK 5.14	−SEK 2.66
Cash flow
Operating cash flow	−SEK 380.5M	−SEK 341.7M	−SEK 41.2M	−SEK 245.8M	−SEK 62.6M
Capital expenditure	SEK 10.0M	SEK 13.3M	SEK 12.4M	SEK 13.3M	SEK 6.7M
Free cash flow	−SEK 390.5M	−SEK 355.0M	−SEK 53.6M	−SEK 259.1M	−SEK 69.3M
Balance sheet
Cash and equivalents	SEK 434.8M	SEK 259.5M	SEK 515.0M	SEK 910.8M	SEK 729.3M
Total assets	SEK 989.2M	SEK 1.40B	SEK 1.71B	SEK 1.45B	SEK 802.6M
Total liabilities	SEK 103.4M	SEK 90.5M	SEK 106.1M	SEK 80.3M	SEK 59.1M
Shareholders' equity	SEK 885.8M	SEK 1.31B	SEK 1.61B	SEK 1.37B	SEK 743.5M

TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in SEK as reported; per-share data adjusted for stock splits.

Annual reports

More on the interactive page

The full BINV.ST page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.

Open BINV.ST financials →